RAC
Click for more information
1.27% $1.55 race oncology ltd

I think RACE have focused on Melanoma and Renal Cancer initially...

  1. wombat777
    11,249 Posts.
    lightbulb Created with Sketch. 29637
    clock Created with Sketch.
    09/01/21
    20:04
    Post #: 50058883
    I think RACE have focused on Melanoma and Renal Cancer initially due to potential to pair it with the PD-1 inhibitors.

    Given the speed at which Merck achieved approvals for Keytruda ( over 30 in 7 years ), Big Pharma will ultimately be the ones to have the best crack at accelerating approvals for indications like Pancreatic Cancer (subject to successful trials of course).
    RAC Price at posting: $1.72 Sentiment: Buy Disclosure: Held
    Likes Created with Sketch. 22  Upvote
    lightbulb Created with Sketch.  Great analysis
    Stroke 3 Created with Sketch. Comments Created with Sketch. Reply

  2. Top Stories

 

Featured News

STX Award of 85 MW capacity pushes Strike's Erregulla power station project closer to FID
right-arrow Created with Sketch.
G88 Golden Mile ditches Marble Bar and Murchison tenements after weak fieldwork results
right-arrow Created with Sketch.
WNX Wellnex sees first special access scheme prescriptions for new Wellness Life brand
right-arrow Created with Sketch.
AWJ Jeffrey's Find delivered $6.3M in gold sales for August, says Auric
right-arrow Created with Sketch.
MOV MOVE Logistics picks new interim CEO to take over operations from early September
right-arrow Created with Sketch.
GBR Great Boulder reports mineralisation over 400m of strike at Mulga Bill North
right-arrow Created with Sketch.
watchlist Created with Sketch. Add RAC (ASX) to my watchlist
(20min delay)
Last
$1.55 		Change
-0.020(1.27%) 		Mkt cap ! $264.0M
Open High Low Value Volume
$1.59 $1.62 $1.51 $218.3K 138.7K

Buyers (Bids)

No. Vol. Price($)
1 95 $1.53
 

Sellers (Offers)

Price($) Vol. No.
$1.55 157 1
View Market Depth
Last trade - 16.10pm 16/08/2024 (20 minute delay) ?
RAC (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.